Abciximab
Summary
Risk. Use of amino acids, peptides and proteins has been considered to result in insignificant environmental impact.
This summary information comes from Fass.
Detailed information
Fass environmental information
Fass environmental information for ReoPro (abciximab) from Janssen (downloaded 2019-09-04).
Risk
Use of amino acids, peptides and proteins has been considered to result in insignificant environmental impact.
Detailed information
According to the European Medicines Agency guideline on environmental risk assessments for pharmaceuticals (EMA/CHMP/SWP/4447/00),vitamins, electrolytes, amino acids, peptides, proteins, carbohydrates, lipids proteins, vaccines and herbal medicinal products are exempted because they are unlikely to result in significant risk to the environment.
Author: Health and Medical Care Administration, Region Stockholm